Precision medicine decision-making under pharmacogenomics in nursing: realizing value from limited evidence to scaled clinical pathways.

Qin G, Luo X, Hao X, Xiao H, Wang K, Pang H, Li M, Pi C, Yang S, Zhang Q

Open source

DOI
10.3389/fneur.2026.1808157
Published
2026
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1808157,
  title = {Precision medicine decision-making under pharmacogenomics in nursing: realizing value from limited evidence to scaled clinical pathways.},
  author = {Qin G and Luo X and Hao X and Xiao H and Wang K and Pang H and Li M and Pi C and Yang S and Zhang Q},
  year = {2026},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2026.1808157},
  url = {https://doi.org/10.3389/fneur.2026.1808157}
}

RIS

TY  - JOUR
TI  - Precision medicine decision-making under pharmacogenomics in nursing: realizing value from limited evidence to scaled clinical pathways.
AU  - Qin G
AU  - Luo X
AU  - Hao X
AU  - Xiao H
AU  - Wang K
AU  - Pang H
AU  - Li M
AU  - Pi C
AU  - Yang S
AU  - Zhang Q
PY  - 2026
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2026.1808157
UR  - https://doi.org/10.3389/fneur.2026.1808157
ER  - 

APA

G, Q., X, L., X, H., H, X., K, W., H, P., M, L., C, P., S, Y., & Q, Z. (2026). Precision medicine decision-making under pharmacogenomics in nursing: realizing value from limited evidence to scaled clinical pathways.. Frontiers in neurology. https://doi.org/10.3389/fneur.2026.1808157

Source records